0001193125-26-199339
SEC filingExceptional quarter driven by Pharmacy Solutions mix shift and the Provider Services acquisition, with net income surging 404% YoY.
The Provider Services segment contributed to revenue growth through the acquisition of Amedisys/LHC Group, which expanded the company's home health, hospice, and community-based service offerings. The acquisition aligns with BrightSpring's strategy to coordinate base pharmacy and provider services, driving improved quality and lower costs for value-based care constructs. The company's focused build-out of Home-Based Primary Care, transitional care programs, and the Clinical (Nursing) Hub are key enablers for this coordination.
Net income increased 403.6% to $148.8 million, compared to $29.5 million in the prior year quarter. The significant increase was primarily due to a $103.4 million gain on the sale of the Community Living segment, which was divested during the quarter. Operating income rose 139.4% to $121.4 million, reflecting the revenue growth and operating leverage. Diluted earnings per share increased to $0.67 from $0.14 in the prior year quarter.
BrightSpring continues to focus on its integrated care model, leveraging its pharmacy and provider services to reduce healthcare costs in lower-cost settings. The divestiture of the Community Living segment is expected to augment revenue and Adjusted EBITDA growth rates and maximize exposure to target growth markets such as home health, hospice, rehab, and primary care. However, the company faces potential labor cost increases due to a shortage of qualified caregivers, and demand for homecare services is expected to grow.